Marianna Trakala

Marianna Trakala

Auto-generated profile, based on publicly available information

Marianna Trakala

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MÁMónica Álvarez-Fernández
Mónica Álvarez-Fernández
RSRuth Sánchez-Martínez
Ruth Sánchez-Martínez
BSBelén Sanz-Castillo
Belén Sanz-Castillo
PGPei Pei Gan
Pei Pei Gan
MSMaría Sanz-Flores
María Sanz-Flores
MMMarcos Malumbres
Marcos Malumbres
Greatwall is a protein kinase involved in the inhibition of protein phosphatase 2 (PP2A)-B55 complexes to maintain the mitotic state. Although its biochemical activity has been deeply characterized in Xenopus, its specific relevance during the progression of mitosis is not fully understood. By using a conditional knockout of the mouse ortholog, Mastl, we show here that mammalian Greatwall is essential for mouse embryonic development and cell cycle progression. Yet, Greatwall-null cells enter into mitosis with normal kinetics. However, these cells display mitotic collapse after nuclear envelope breakdown (NEB) characterized by defective chromosome condensation and prometaphase arrest. Intriguingly, Greatwall is exported from the nucleus to the cytoplasm in a CRM1-dependent manner before NEB. This export occurs after the nuclear import of cyclin B–Cdk1 complexes, requires the kinase activity of Greatwall, and is mediated by Cdk-, but not Polo-like kinase 1-dependent phosphorylation. The mitotic collapse observed in Greatwall-deficient cells is partially rescued after concomitant depletion of B55 regulatory subunits, which are mostly cytoplasmic before NEB. These data suggest that Greatwall is an essential protein in mammals required to prevent mitotic collapse after NEB.

1 October 2015 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
AGAlejandra González-Loyola
Alejandra González-Loyola
GFGonzalo Fernández-Miranda
Gonzalo Fernández-Miranda
MTMarianna Trakala
Marianna Trakala
DPDavid Partida
David Partida
KSKumiko Samejima
Kumiko Samejima
MMMarcos Malumbres
Marcos Malumbres
Aurora kinase B, one of the three members of the mammalian Aurora kinase family, is the catalytic component of the chromosomal passenger complex, an essential regulator of chromosome segregation in mitosis. Aurora B is overexpressed in human tumors although whether this kinase may function as an oncogene in vivo is not established. Here, we report a new mouse model in which expression of the endogenous Aurkb locus can be induced in vitro and in vivo. Overexpression of Aurora B in cultured cells induces defective chromosome segregation and aneuploidy. Long-term overexpression of Aurora B in vivo results in aneuploidy and the development of multiple spontaneous tumors in adult mice, including a high incidence of lymphomas. Overexpression of Aurora B also results in a reduced DNA damage response and decreased levels of the p53 target p21Cip1in vitro and in vivo, in line with an inverse correlation between Aurora B and p21Cip1 expression in human leukemias. Thus, overexpression of Aurora B may contribute to tumor formation not only by inducing chromosomal instability but also by suppressing the function of the cell cycle inhibitor p21Cip1.

1 July 2011 in Development
Verified
Journal Article
Open access
PDF file
GFGonzalo Fernández-Miranda
Gonzalo Fernández-Miranda
MTMarianna Trakala
Marianna Trakala
JMJavier Martín
Javier Martín
BEBeatriz Escobar
Beatriz Escobar
AGAlejandra González
Alejandra González
MMMarcos Malumbres
Marcos Malumbres
Mitosis is controlled by multiple kinases that drive cell cycle progression and prevent chromosome mis-segregation. Aurora kinase B interacts with survivin, borealin and incenp to form the chromosomal passenger complex (CPC), which is involved in the regulation of microtubule-kinetochore attachments and cytokinesis. Whereas genetic ablation of survivin, borealin or incenp results in early lethality at the morula stage, we show here that aurora B is dispensable for CPC function during early cell divisions and aurora B-null embryos are normally implanted. This is due to a crucial function of aurora C during these early embryonic cycles. Expression of aurora C decreases during late blastocyst stages resulting in post-implantation defects in aurora B-null embryos. These defects correlate with abundant prometaphase figures and apoptotic cell death of the aurora B-deficient inner cell mass. Conditional deletion of aurora B in somatic cells that do not express aurora C results in chromosomal misalignment and lack of chromosome segregation. Re-expression of wild-type, but not kinase-dead, aurora C rescues this defect, suggesting functional overlap between these two kinases. Finally, aurora B-null cells partially arrest in the presence of nocodazole, suggesting that this kinase is not essential for the spindle assembly checkpoint.

10 April 2019 in Nature
Verified
Journal Article
Open access
PDF file
ATAntonia Tomás-Loba
Antonia Tomás-Loba
EMElisa Manieri
Elisa Manieri
BGBárbara González-Terán
Bárbara González-Terán
AMAlfonso Mora
Alfonso Mora
LLLuis Leiva-Vega
Luis Leiva-Vega
GSGuadalupe Sabio
Guadalupe Sabio
The cell cycle is a tightly regulated process that is controlled by the conserved cyclin-dependent kinase (CDK)–cyclin protein complex1. However, control of the G0-to-G1 transition is not completely understood. Here we demonstrate that p38 MAPK gamma (p38γ) acts as a CDK-like kinase and thus cooperates with CDKs, regulating entry into the cell cycle. p38γ shares high sequence homology, inhibition sensitivity and substrate specificity with CDK family members. In mouse hepatocytes, p38γ induces proliferation after partial hepatectomy by promoting the phosphorylation of retinoblastoma tumour suppressor protein at known CDK target residues. Lack of p38γ or treatment with the p38γ inhibitor pirfenidone protects against the chemically induced formation of liver tumours. Furthermore, biopsies of human hepatocellular carcinoma show high expression of p38γ, suggesting that p38γ could be a therapeutic target in the treatment of this disease.

1 January 2015 in Developmental Cell
Verified
Journal Article
Closed access
MTMarianna Trakala
Marianna Trakala
SRSara Rodríguez-Acebes
Sara Rodríguez-Acebes
MMMaría Maroto
María Maroto
CSCatherine E. Symonds
Catherine E. Symonds
DSDavid Santamaría
David Santamaría
MMMarcos Malumbres
Marcos Malumbres

15 July 2021 in Genes & Development
Verified
Journal Article
Open access
PDF file
MTMarianna Trakala
Marianna Trakala
MAMuskaan Aggarwal
Muskaan Aggarwal
CSCourtney Sniffen
Courtney Sniffen
LZLauren Zasadil
Lauren Zasadil
ACAllison Carroll
Allison Carroll
AAAngelika Amon
Angelika Amon
Chromosome gains and losses are a frequent feature of human cancers. However, how these aberrations can outweigh the detrimental effects of aneuploidy remains unclear. An initial comparison of existing chromosomal instability (CIN) mouse models suggests that aneuploidy accumulates to low levels in these animals. We therefore developed a novel mouse model that enables unprecedented levels of chromosome missegregation in the adult animal. At the earliest stages of T-cell development, cells with random chromosome gains and/or losses are selected against, but CIN eventually results in the expansion of progenitors with clonal chromosomal imbalances. Clonal selection leads to the development of T-cell lymphomas with stereotypic karyotypes in which chromosome 15, containing the Myc oncogene, is gained with high prevalence. Expressing human MYC from chromosome 6 (MYCChr6) is sufficient to change the karyotype of these lymphomas to include universal chromosome 6 gains. Interestingly, while chromosome 15 is still gained in MYCChr6 tumors after genetic ablation of the endogenous Myc locus, this chromosome is not efficiently gained after deletion of one copy of Rad21, suggesting a synergistic effect of both MYC and RAD21 in driving chromosome 15 gains. Our results show that the initial detrimental effects of random missegregation are outbalanced by clonal selection, which is dictated by the chromosomal location and nature of certain genes and is sufficient to drive cancer with high prevalence.